Biosensors International Group, Ltd

We're #hiring a new MedizintechnikingenieurIN (m/w/d) in Hechingen, Baden-Württemberg. Apply today or share this post with your network.

We're #hiring a new Sales Specialist in Georgetown, Penang. Apply today or share this post with your network.

It was such an honor to participate in this fantastic event, brilliantly led by Ioannis Iakovou and Mamas Mamas, discussing important topics such as HBR, ACS, CHIP and emerging technologies. Biosensors International Group, Ltd Mamas Mamas IOANNIS IAKOVOU

🌍 Three international events in one week? Yes, it's possible! 🗓️ 🛫 6 flights, keynote speeches, and practical workshops in Turkey 🇹🇷, Greece 🇬🇷, and India 🇮🇳. The Advanced Therapy Summit #ATS and #Allegra Master Class were incredible opportunities to connect with international colleagues and share knowledge. A big thanks to John Alilovic and all the organizing team from Biosensors International Group, Ltd for making it happen. Reconnecting with my friend Matthias Bossard and reminiscing about our time at Luzerner Kantonsspital was a highlight. Special thanks to my mentor Stefan Toggweiler whose guidance continues to inspire me. A special mention to RAVI KUMAR PATNAIK and the panel members for the insightful discussions at CSI NIC Meet, India's largest cardiology conference. #Multitasking #TimeManagement #LSMU #Biosensors #Allegra #Relisys Lithuanian University of Health Sciences

Delighted to have Professor Ioannis Iakovou, Director, Interventional Cardiology at Onassis Cardiac Surgery Center in Attiki, Greece & co chair Mamas Mamas, Professor of Cardiology at Keele University welcome us all to the opening of the Biosensors International Advanced Therapies Summit here in Athens from July 4-5, 2024. Looking forward to learning more from our many keynote speakers on PCI & Structural Heart. #Education #PCI #TAVI #coronary #structuralheart #Innovation #Patientsfirst

Biosensors International wishes to announce that Prof Keith Oldroyd has stepped down from his role as Chief Medical Officer effective June 30th, 2024. Biosensors would like to thank Keith for his invaluable contribution to the success of the company over the past 4 years. Prof Oldroyd will continue to provide advice and support to the company as an external consultant and proctor.   Biosensors International is delighted to announce that Dr Anders Jönsson, currently serving as Director Medical Affairs, will take up the role of Chief Medical Officer, effective July 1st, 2024. Anders is a cardiac surgeon with extensive experience in both structural and coronary heart disease, including the minimally invasive treatment of mitral and aortic valve disease. Keith and Anders have been working very closely together for the past two years and this will ensure a seamless transition with no interruption to our extensive program of product development and clinical trials. #PioneeringTechnology #newCMO #clinicaltrials #structuralheart #coronary

Premiere in Germany! We are delighted to announce that Dr. Klaus Hertting & his team from the Krankenhaus Buchholz und Winsen gemeinnützige GmbH have enrolled the first patient in the ALPHA LONG clinical study in Germany. The responsible study nurse was Liana Hertting. The stent was a BioMatrix™ Alpha 3.0 x 42mm stent implanted. This study will support regulatory approval of new longer length (up to 48mm) versions of BioMatrix™ Alpha. A parallel study with longer versions of BioFreedom™ Ultra is currently ongoing. Congratulations! #KrankenhausBuchholzl #PCI #interventionalcardiology #biosensors #stent #clinicalstudy #innovation #medicaldevices #pioneeringtechnology

The Experience by Excellence event at the Hospital Alvaro Cunquieiro in Vigo, Spain featured theoretical training, hands-on sessions on how to use the ALLEGRA™ TAVI System transfemoraly in Aortic Stenosis patients. Our guests from the Czech Republic, Dr. Jan Sitar and Dr. Ladislav Groch, along with their distributor Jan Duda (Acare), gained valuable insights into the outstanding performance of the ALLEGRA™ implantations. A big thank you to Dr. José Antonio Baz and the entire Cath-lab team! #ALLEGRA #ExperienceByExcellence #MedicalTraining #TAVI #Cardiology #Healthcare #Innovation #Collaboration #Vigo #Spain

We are excited to announce the first successful ALLEGRA™ cases performed at Semmelweis Egyetem Hospital in Budapest, led by the esteemed Prof. Béla Merkely MD, PhD, MSC, DSC, FESC, FACC, alongside Dr. Levente Molnár MD, Head of Structural. The team achieved excellent hemodynamic results. A heartfelt congratulations to Prof. Béla Merkely and his outstanding team for this wonderful start.  Special thanks to Prof. Keith Oldroyd and Lars Arnold from Biosensors International for their invaluable support. #MedicalInnovation #ALLEGRA #HealthcareExcellence #Teamwork #PatientCare

4 ALLEGRA™ implantations, including a Valve-in-Valve procedure in a Perceval valve, were successfully performed at Hospital La Fe in Valencia (Spain) during the “Experience by Excellence” session on Wednesday. Dr. Jorge Sanz Sánchez Sanz took the time to meticulously explain all relevant implantation steps to the trainees attending the event. Congratulations and a big THANK YOU to the entire Cath-lab team. We look forward to continuing our successful collaboration! #ALLEGRA #ValveInValve #MedicalInnovation #HealthcareExcellence #CathLab #Cardiology #HospitalLaFe #Valencia #ExperienceByExcellence #Teamwork